World IVD Market Prospects Reviewed in New Industry Experts Report Now Available at

Share Article

New research report “In Vitro Diagnostics - A Global Market Overview” elaborated by Industry Experts has been recently published by Market Publishers Ltd. The report indicates that the global IVD market is estimated to touch USD 51.2 billion and USD 53.5 billion in 2012 and 2013 respectively.

TD The Market Publishers Ltd

The global in vitro diagnostic (IVD) market is estimated to touch USD 51.2 billion and USD 53.5 billion in 2012 and 2013, respectively, with molecular diagnostics being the largest growing segment of the market.

The key factors driving the growth of the IVD market globally is increased patient awareness, patient self testing, growing baby booming population, the advancement in the technology bringing more of automated tests, as well as the rise in the number of certain diseases.

New research report “In Vitro Diagnostics - A Global Market Overview” elaborated by Industry Experts has been recently published by Market Publishers Ltd.

Report Details:

Title: In Vitro Diagnostics - A Global Market Overview
Published: May, 2012
Pages: 493
Price: US$ 4,500.00

The report reviews, analyzes and projects the IVD market globally and across individual regions, including North America, Europe, the Asia-Pacific, South America and ROW, with the regional markets further analyzed for 22 independent countries. The study contains statistical data for the global market by geographic region, product category and application area, and provides profiles of 47 key global players and 60 major players across the United States – 36, Europe – 18, and the Asia-Pacific – 6. A global listing of 382 companies engaged in R&D, equipment manufacturing, processing, supplies and distribution of IVD products is also provided.

IVD product categories mentioned include: reagents & consumables, instruments & systems.

IVD application areas covered are: clinical chemistry, immunoassay, diabetes testing, blood testing, molecular diagnostics, pathology, cellular analysis and microbiology.

Report Contents:

Part A: Global Market Perspective

1. Introduction

1.1 Product Outline
1.1.1 Positives
1.1.2 Precision of IVDs
1.1.3 Type of Products Used For In Vitro Diagnostics General Purpose Reagents Analyte Specific Reagents Biochemical and Chemical Reagents: An Overview Opting for the Optimal Biochemical and Chemical Reagents for IVD Tests

2. A Snapshot of End-Use Applications

2.1 Clinical Chemistry
2.1.1 Clinical Chemistry Analyzers
2.2 Immunoassays
2.2.1 Objective of Immunoassays
2.2.2 Immunoassay Methodologies
2.3 Diabetes Testing
2.3.1 Primary Types of Diabetes
2.3.2 Prediabetes
2.3.3 Diagnosis of Diabetes and Prediabetes Fasting Plasma Glucose (FPG) Test Oral Glucose Tolerance Test (OGTT) Random Plasma Glucose Test
2.4 Blood Testing
2.4.1 Categories of Blood Tests Complete Blood Count (CBC) Red Blood Cells White Blood Cells Platelets Hemoglobin Hematocrit Mean Corpuscular Volume (MCV)
2.4.2 Blood Chemistry Tests/Biochemical Analysis
2.5 Molecular Diagnostics
2.5.1 Molecular Diagnostics Techniques
2.5.2 Molecular Diagnostics and Genome Research
2.5.3 Molecular Diagnostics Tools Sample Collection and Preparation Amplification and Detection Platforms and Assays Software Tools Complete Solutions
2.5.4 What the Future Holds for Molecular Tools
2.6 Pathology
2.6.1 Anatomical Pathology
2.6.2 Chemical Pathology
2.6.3 Clinical Pathology
2.6.4 Forensic Pathology
2.6.5 General Pathology
2.6.6 Genetic Pathology
2.6.7 Hematology Pathology
2.6.8 Immunopathology
2.6.9 Microbiology
2.7 Microbiology

3. Key Market Trends

Glucose Levels to be Measured via Breath with New Diabetes Device
New Technology to Protect Insulin in Africa
Depressed? Get a Blood Test
3-D Microscopy Assistance for Cell Analysis
Bacteria-Based Test Strips for Detecting Glucose Levels in Diabetics in the Offing
Mid-2012 Set Timeline for FDA for Issuing Final Guidance for In Vitro Companion Diagnostics
The 2011 Draft Guidance
Companion Diagnostic Tests
Diabetes Testing Made Easier with New Technology
In-Vitro Nanodiagnostics to Detect Pathogens: Contemporary Trends
Clinical Laboratories Offer Physicians New Diagnostic Technology for Speedier and Better Diagnosis
New Blood Test to Detect Alzheimer's Five Years Beforehand
Early Diagnosis of Cryptococcosis Aided by New Rapid Blood Test
Diagnosis of Mesothelioma Could be Done Earlier with New Blood Test
Challenges Confronting Western Europe’s In Vitro Diagnostics Industry and Probable Solutions
Challenges Faced by the Industry
What the Industry Needs to Accomplish
“Cry” for Measuring Blood Glucose Levels
Diabetes Care Alleviated with New Tool that Saves Time and Reduces Error Risks
Future Role of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
Metabolomic Profiling in Clinical Medicine
Diagnosing Heart Attacks with a New Blood Test
Problems Associated with Paucity in Diagnostic Tests

More new market research reports by the publisher can be found at Industry Experts page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website